1. Home
  2. DVA vs DOCS Comparison

DVA vs DOCS Comparison

Compare DVA & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • DOCS
  • Stock Information
  • Founded
  • DVA 1994
  • DOCS 2010
  • Country
  • DVA United States
  • DOCS United States
  • Employees
  • DVA N/A
  • DOCS N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • DOCS Retail: Computer Software & Peripheral Equipment
  • Sector
  • DVA Health Care
  • DOCS Technology
  • Exchange
  • DVA Nasdaq
  • DOCS Nasdaq
  • Market Cap
  • DVA 15.2B
  • DOCS 13.2B
  • IPO Year
  • DVA 1995
  • DOCS 2021
  • Fundamental
  • Price
  • DVA $147.01
  • DOCS $64.00
  • Analyst Decision
  • DVA Hold
  • DOCS Buy
  • Analyst Count
  • DVA 5
  • DOCS 16
  • Target Price
  • DVA $154.40
  • DOCS $63.63
  • AVG Volume (30 Days)
  • DVA 1.3M
  • DOCS 3.5M
  • Earning Date
  • DVA 05-01-2025
  • DOCS 02-06-2025
  • Dividend Yield
  • DVA N/A
  • DOCS N/A
  • EPS Growth
  • DVA 44.61
  • DOCS 49.41
  • EPS
  • DVA 10.73
  • DOCS 1.00
  • Revenue
  • DVA $12,815,550,000.00
  • DOCS $550,168,000.00
  • Revenue This Year
  • DVA $5.76
  • DOCS $21.45
  • Revenue Next Year
  • DVA $3.59
  • DOCS $12.37
  • P/E Ratio
  • DVA $13.70
  • DOCS $63.95
  • Revenue Growth
  • DVA 5.56
  • DOCS 17.47
  • 52 Week Low
  • DVA $125.64
  • DOCS $22.96
  • 52 Week High
  • DVA $179.60
  • DOCS $85.21
  • Technical
  • Relative Strength Index (RSI)
  • DVA 41.48
  • DOCS 42.58
  • Support Level
  • DVA $138.64
  • DOCS $65.15
  • Resistance Level
  • DVA $149.06
  • DOCS $69.91
  • Average True Range (ATR)
  • DVA 4.76
  • DOCS 3.24
  • MACD
  • DVA -0.71
  • DOCS -1.65
  • Stochastic Oscillator
  • DVA 42.77
  • DOCS 6.39

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About DOCS Doximity Inc.

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Share on Social Networks: